Comparison of complications between transcatheter and surgical ventricle septal defect closure: a single-center cohort study

  • Deny Salverra Yosy Department of Child Health, Medical School, Universitas Sriwijaya/Mohammad Hoesin Hospital, Palembang, Indonesia https://orcid.org/0000-0003-2529-9320
  • Mulyadi Muhammad Djer Department of Child Health, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Sukman Tulus Putra Department of Child Health, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
DOI: https://doi.org/10.13181/mji.oa.203837
Keywords: complication, surgery, transcatheter, ventricular septal defect
Abstract viewed: 778 times
PDF downloaded: 886 times
HTML downloaded: 77 times
EPUB downloaded: 165 times

Abstract

BACKGROUND Some ventricular septal defects (VSDs) require an interventional procedure for closure. Transcatheter and surgical closures of VSD have similar effectiveness, but transcatheter VSD closure is considered associated with less complication than surgical closure. This study aimed to compare mid-term or long-term complications of transcatheter and surgical VSD closures.

METHODS This was a retrospective cohort study compared the complication rates of transcatheter and surgical VSD closures performed in Cipto Mangunkusumo Hospital from January 1, 2010, to April 30, 2017, with 34 subjects in each group. The inclusion criteria were as follows: single lesion outlet perimembranous or doubly committed subarterial VSD, age 218 years, body weight >8 kg, and no arrhythmia. Electrocardiography and echocardiography were done to collect primary data. Other data were collected from medical records. Mid-term complications occurred 124 months after interventional closure. Long-term complications occurred 24 months after interventional closure. Complications were arrhythmia, valve regurgitation, and residual shunt. Data were analyzed by chi-square test.

RESULTS The rate of worsening valve regurgitation was higher in the transcatheter group than in the surgical group (16 versus 11, p = 0.322). The number of patients with residual shunts were similar between the transcatheter group and surgical group (5 versus 5; p = 1.000). Both complications were found in mid- and long-term. Arrhythmia as a long-term complication occurred in five and seven patients in the transcatheter and surgical groups, respectively (p = 0.752).

CONCLUSIONS Transcatheter and surgical VSD closures have similar mid or long-term complications.

References

  1. Park MK. Pediatric cardiology for practitioners. 6th ed. Philadelphia: Saunders Elsevier; 2014. p. 3-76, 155-84.

  2. Gatea SK, Janabi AK. Natural history of isolated ventricular septal defects in the first two years of life. Qatar Med J. 2010;6:147-60.

  3. Chaudhry TA, Younas M, Baig A. Ventricular septal defect and associated complications. J Pak Med Assoc. 2011;61:1001-4.

  4. Djer MM, Putra ST, Ulfa A, Roebiono PS, Rahman AR, Noormanto, et al. Penatalaksanaan penyakit jantung bawaan. Jakarta: Departemen Kesehatan RI; 2007. [Indonesian].

  5. Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M. Transcatheter closure of congenital muscular ventricular septal defect. J Interven Cardiol. 2004;17:109-15. https://doi.org/10.1111/j.1540-8183.2004.09872.x

  6. Liu J, Wang Z, Gao L, Tan HL, Zheng Q, Zhang ML. A large institutional study on outcomes and complications after transcatheter closure of a perimembranous-type ventricular septal defect in 890 cases. Acta Cardiol Sin. 2013;29:271-6.

  7. McDaniel NL. Ventricular and atrial septal defects. Pediat Rev. 2001;22:265-9. https://doi.org/10.1542/pir.22-8-265

  8. Wojtalik MP, Wojtalik M, Mrówczyñski W, Surmacz R. Closure of perimembranous ventricular septal defect using transcatheter technique versus surgical repair. Kardiol Pol. 2005;63:595-602.

  9. Oses P, Hugues N, Dahdah N, Vobecky SJ, Miro J, Pellerin M, et al. Treatment of isolated ventricular septal defects in children: Amplatzer versus surgical closure. Ann Thorac Surg. 2010;90:1593-8. https://doi.org/10.1016/j.athoracsur.2010.06.088

  10. Yang J, Yang L, Yu S, Liu J, Zuo J, Chen W, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. 2014;63:1159-68. https://doi.org/10.1016/j.jacc.2014.01.008

  11. Narin N, Baykan A, Argun M, Özyurt A, Pamukçu Ö, Sezer A, et al. Single-center results of the use of transcatheter closure forventricular septal defects. Turk Gogus Kalp Dama. 2015;23:448-53. https://doi.org/10.5606/tgkdc.dergisi.2015.9299

  12. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJJC. Follow-up after surgical closure of congenital ventricular septal defect. EJCTS. 2003;24:511-5. https://doi.org/10.1016/S1010-7940(03)00430-5

  13. Azab S, El-Shahawy H, Samy A, Mahdy W. Permanent complete heart block following surgical closure of isolated ventricular septal defect. Egypt J Chest Dis Tuberculosis. 2013;62:529-33 https://doi.org/10.1016/j.ejcdt.2013.03.007

  14. Yang J, Yang L, Wan Y, Zuo J, Zhang J, Chen W, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J. 2010;31:2238-45. https://doi.org/10.1093/eurheartj/ehq240

  15. Waqar T, Rizvi MFA, Baig AR. Doubly committed subarterial ventricular septal defect repair: an experience of 51 cases. Pak J Med Sci. 2017;33(5):1112-6. https://doi.org/10.12669/pjms.335.13429

  16. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med. 2007;8:39-45. https://doi.org/10.2459/01.JCM.0000247434.59451.d7

Published
2020-08-07
How to Cite
1.
Yosy DS, Djer MM, Putra ST. Comparison of complications between transcatheter and surgical ventricle septal defect closure: a single-center cohort study. Med J Indones [Internet]. 2020Aug.7 [cited 2024Apr.27];29(3):268-74. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/3837
Issue
Vol. 29 No. 3 (2020): September
Section
Clinical Research

Copyright (c) 2020 Deny Salverra Yosy, Mulyadi M. Djer, Sukman Tulus Putra

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.